Literature DB >> 16860052

A biodegradable levonorgestrel-releasing implant made of PCL/F68 compound as tested in rats and dogs.

Guilei Ma1, Cunxian Song, Hongfan Sun, Jing Yang, Xigang Leng.   

Abstract

PURPOSE: Our objective was to report preclinical studies on a biodegradable long-acting contraceptive implant.
METHODS: A poly (epsilon-caprolactone) (PCL)/pluronic F68 (F68) compound was used to construct an implant, which was filled with dry levonorgestrel (LNG) powder (PCL/F68/LNG). LNG release rate, contraceptive efficacy and polymer degradation were evaluated in rats and followed for 2 years. A 2-year toxicity study was conducted in dogs.
RESULTS: The in vitro and in vivo release of LNG from the implant followed zero-order release kinetics. Serum LNG level in rats was very stable during the 2-year period. Studies on polymer degradation indicated that the molecular weight of PCL dropped from 66,000 to 15,000 Da, but the implant was still in good shape by the end of 2 years.
CONCLUSION: Toxicological study demonstrated that the PCL/F68 polymer had no adverse effect in all aspects. The contraceptive efficacy in rats showed dose response. The implant was physically and chemically stable for up to 3 years in airproof aluminum foil packing at room temperature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16860052     DOI: 10.1016/j.contraception.2006.02.013

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  9 in total

Review 1.  Long acting systemic HIV pre-exposure prophylaxis: an examination of the field.

Authors:  William R Lykins; Ellen Luecke; Daniel Johengen; Ariane van der Straten; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2017-12       Impact factor: 4.617

2.  Development and in vitro-in vivo evaluation of polymeric implants for continuous systemic delivery of curcumin.

Authors:  Shyam S Bansal; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Pharm Res       Date:  2011-02-11       Impact factor: 4.200

3.  Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts.

Authors:  Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Mutat Res       Date:  2012-01-05       Impact factor: 2.433

4.  Preparation and evaluation of rotigotine-loaded implant for the treatment of Parkinson's disease and its evolution study.

Authors:  Aiping Wang; Yanxiang Liu; Rongcai Liang; Xuemei Zhang; Kaoxiang Sun; Zimei Wu; Wanhui Liu
Journal:  Saudi Pharm J       Date:  2016-05-05       Impact factor: 4.330

Review 5.  Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé®).

Authors:  Francisco de Melo; Pierre Nicolau; Luca Piovano; Shang-Li Lin; Tiago Baptista-Fernandes; Martyn I King; Alessandra Camporese; Kyungkook Hong; Maria M Khattar; Marie-Odile Christen
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-11-08

Review 6.  Minimally Invasive Aesthetic Treatment of the Face and Neck Using Combinations of a PCL-Based Collagen Stimulator, PLLA/PLGA Suspension Sutures, and Cross-Linked Hyaluronic Acid.

Authors:  Francisco de Melo; Alieksiéi Carrijo; Kyungkook Hong; Bruno Trumbic; Franco Vercesi; Heidi A Waldorf; Sabine Zenker
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-05-05

Review 7.  Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics.

Authors:  Marie-Odile Christen; Franco Vercesi
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-01-20

8.  Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial.

Authors:  Marion Michaela Moers-Carpi; Sally Sherwood
Journal:  Dermatol Surg       Date:  2013-01-25       Impact factor: 3.398

9.  Permeation measurement of gestodene for some biodegradable materials using Franz diffusion cells.

Authors:  Danhua Liu; Chong Zhang; Xiaowei Zhang; Zhu Zhen; Ping Wang; Jianxin Li; Dongxu Yi; Ying Jin; Dan Yang
Journal:  Saudi Pharm J       Date:  2015-01-12       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.